Horizon Kinetics Asset Management’s Lantern Pharma LTRN Stock Holding History

Horizon Kinetics Asset Management’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.1K	Sell	26,373 -1,209	-4%	-$3.38K	﹤0.01%	340
2025 Q4	$83.6K	Sell	27,582 -1,209	-4%	-$4.5K	﹤0.01%	317
2025 Q3	$125K	Buy	28,791 +1,209	+4%	+$5.05K	﹤0.01%	319
2025 Q2	$87.2K	Sell	27,582 -1,209	-4%	-$4.08K	﹤0.01%	338
2025 Q1	$102K	Hold	28,791	–	–	﹤0.01%	329
2024 Q4	$91.8K	Buy	28,791 +1,209	+4%	+$4.14K	﹤0.01%	333
2024 Q3	$101K	Sell	27,582 -1,209	-4%	-$4.98K	﹤0.01%	329
2024 Q2	$134K	Hold	28,791	–	–	﹤0.01%	299
2024 Q1	$253K	Hold	28,791	–	–	﹤0.01%	267
2023 Q4	$123K	Sell	28,791 -1,209	-4%	-$4.26K	﹤0.01%	299
2023 Q3	$102K	Hold	30,000	–	–	﹤0.01%	312
2023 Q2	$169K	Hold	30,000	–	–	﹤0.01%	300
2023 Q1	$145K	Buy	+30,000	New	+$158K	﹤0.01%	304

Other funds holding LTRN

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Horizon Kinetics Asset Management's LTRN Position: Q1 2026 in Review

Horizon Kinetics Asset Management reduced its Lantern Pharma (LTRN) stake by 4.4% in Q1 2026, selling an estimated $3.38K and leaving 26,373 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Horizon Kinetics Asset Management first reported a position in LTRN in Q1 2023 and has held it in 13 quarters since. The position peaked at $253K in Q1 2024. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

Horizon Kinetics Asset Management held 26,373 shares of Lantern Pharma worth $36.1K as of Q1 2026.
Horizon Kinetics Asset Management sold 1,209 Lantern Pharma shares in Q1 2026, an estimated $3.38K.
Lantern Pharma made up ﹤0.01% of Horizon Kinetics Asset Management's portfolio in Q1 2026, its #340 holding.
Horizon Kinetics Asset Management first reported a position in Lantern Pharma in Q1 2023 and has held it in 13 quarters since.
Horizon Kinetics Asset Management's Lantern Pharma position peaked at $253K in Q1 2024.
33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q1 2026, filed 15 May 2026.